Rare diseases
Investigational molecules
Locations
Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
PolandStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
PolandStudy on Rezpegaldesleukin for Treating Moderate-to-Severe Atopic Dermatitis in Adults
PolandStudy on Long-Term Safety of Cendakimab for Adults and Adolescents with Eosinophilic Esophagitis
PolandStudy of Baricitinib for Children and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandStudy of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression
PolandStudy of Different Doses of Amlitelimab Given by Injection Under the Skin in Adults with Moderate to Severe Asthma
PolandStudy on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn's Disease
PolandStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
PolandStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
PolandStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
PolandStudy of benralizumab compared to placebo for treatment of patients with Hypereosinophilic Syndrome (HES)
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
